Myopia: Not Merely an Inconvenience but a Crisis

Myopia, or nearsightedness, is increasingly prevalent globally, particularly among children and young adults, representing the most common refractive error. While significant eye growth occurs during adolescence, the precise causes of myopia progression remain unclear. The COVID-19 pandemic has exacerbated existing challenges, highlighting the urgent need for comprehensive understanding and intervention. Myopia is associated with various ocular disorders, leading to potential permanent vision impairment if left untreated, emphasizing the importance of timely screening and early treatment initiation. This article examines factors contributing to myopia progression and explores methods for halting its advancement. It aims to explore the potential causal mechanisms underlying myopia onset, highlighting emerging research paradigms and novel insights into ocular physiology. By clarifying the underlying pathophysiological pathways, this article seeks to inform targeted interventions aimed at arresting myopia progression and preserving visual acuity. The article surveys therapeutic modalities aimed at halting myopia progression, ranging from traditional optical corrections to behavioural interventions. In summary, this article provides a comprehensive exploration of myopia, covering its etiology, progression, and management strategies. By synthesising current research findings and perspectives, it aims to deepen understanding of this growing public health challenge and inform targeted interventions to alleviate its global burden.